Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

MLA

Kapetanovic, Izet M., et al. “Murine Oncogenicity and Pharmacokinetics Studies of 9-Cis-UAB30, an RXR Agonist, for Breast Cancer Chemoprevention.” International Journal of Toxicology, vol. 29, no. 2, Mar. 2010, pp. 157–64. EBSCOhost, https://doi.org/10.1177/1091581809360070.

APA

Kapetanovic, I. M., Horn, T. L., Johnson, W. D., Cwik, M. J., Detrisac, C. J., & McCormick, D. L. (2010). Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention. International Journal of Toxicology, 29(2), 157–164. https://doi.org/10.1177/1091581809360070

Chicago

Kapetanovic, Izet M, Thomas L Horn, William D Johnson, Michael J Cwik, Carol J Detrisac, and David L McCormick. 2010. “Murine Oncogenicity and Pharmacokinetics Studies of 9-Cis-UAB30, an RXR Agonist, for Breast Cancer Chemoprevention.” International Journal of Toxicology 29 (2): 157–64. doi:10.1177/1091581809360070.